In a move to expand its ophthalmic platform, Sandoz, the former generics and biosimilars arm of Swiss drugmaker Novartis, has completed the acquisition of Coherus...
Hungary-headquartered specialty pharmaceutical company Gedeon Richter becomes a strategic investor of German biosimilars company Formycon via cash capital increase of 9...
With their triumphant advance, biosimilars are also setting in motion the usual market mechanisms. Biopharma interest groups warn against the automatic substitution of...
US drugstore chain CVS Health has launched Cordavis, a wholly owned subsidiary that will collaborate with manufacturers to commercialize and co-produce biosimilar...
26.02.2019
- The EU is adopting new rules that should make it easier for producers of generic drugs and biosimilars in member states to compete on the global market. On Feb. 20, the states...
29.11.2018
- The MENA (Middle East and North Africa) region is a largely untapped, yet potentially hugely fruitful part of the world for the pharmaceutical industry, both as a sales region and...